Cited by 185Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchGenetic Neurodegenerative Diseases

Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion

Open access
Khan, Baber K, Yokoyama, Jennifer S, Takada, Leonel T, Sha, Sharon J, Rutherford, Nicola J, Fong, Jamie C, Karydas, Anna M, Wu, Teresa +13 more·2012·Journal of Neurology, Neurosurgery & Psychiatry

Abstract

BACKGROUND: Some patients meeting behavioural variant frontotemporal dementia (bvFTD) diagnostic criteria progress slowly and plateau at mild symptom severity. Such patients have mild neuropsychological and functional impairments, lack characteristic bvFTD brain atrophy and have thus been referred to as bvFTD 'phenocopies' or slowly progressive (bvFTD-SP). The few patients with bvFTD-SP that have been studied at autopsy have demonstrated no evidence of FTD pathology, suggesting that bvFTD-SP is neuropathologically distinct from other forms of FTD. Here, two patients with bvFTD-SP with chromosome 9 open reading frame 72 (C9ORF72) hexanucleotide expansions are described. METHODS: 384 patients with an FTD clinical spectrum and Alzheimer's disease diagnoses were screened for C9ORF72 expansion. Two bvFTD-SP mutation carriers were identified. Neuropsychological and functional data, as well as brain atrophy patterns, assessed using voxel based morphometry (VBM), were compared with 44 patients with sporadic bvFTD and 85 healthy controls. RESULTS: Both patients were aged 48 years at baseline and met possible bvFTD criteria. In the first patient, VBM revealed thalamic and posterior insula atrophy. Over 7 years, his neuropsychological performance and brain atrophy remained stable. In the second patient, VBM revealed cortical atrophy with subtle frontal and insular volume loss. Over 2 years, her neuropsychological and functional scores as well as brain atrophy remained stable. CONCLUSIONS: C9ORF72 mutations can present with a bvFTD-SP phenotype. Some bvFTD-SP patients may have neurodegenerative pathology, and C9ORF72 mutations should be considered in patients with bvFTD-SP and a family history of dementia or motor neuron disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp-2011-301883

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C9orf72 repeat expansion carriers can present with psychiatric symptoms and form a diagnostic challenge given their slow progressive course and atypical findings in neuroimaging.

    “C9orf72 repeat expansion carriers can present with psychiatric symptoms and form a diagnostic challenge given their slow progressive course and atypical findings in neuroimaging (see 'Genetic testing' section) (Khan et al. , 2012; Solje et al. , 2015; Ducharme et al. , 2017).”
  • Family histories in C9orf72 mutation carriers can be negative or ambiguous due to the large variation in clinical phenotype, including psychiatric and other atypical presentations.

    “It is well known, however, that family histories in C9orf72 mutation carriers can be negative or ambiguous due to the large variation in clinical phenotype, including psychiatric and other atypical presentations.61”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Khan, B. K., Yokoyama, J. S., Takada, L. T., Sha, S. J., Rutherford, N. J., Fong, J. C., Karydas, A. M., Wu, T., Ketelle, R. S., Baker, M. C., Hernandez, M.-D., Coppola, G., Geschwind, D. H., Rademakers, R., Lee, S. E., Rosen, H. J., Rabinovici, G. D., Seeley, W. W., Rankin, K. P., Boxer, A. L., & Miller, B. L.
Affiliations
  • University of California, San Francisco (US)
  • Mayo Clinic in Florida (US)
  • University of California, Los Angeles (US)
Corresponding author
Boxer, Adam L
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2012-03-07
Volume
83
Issue
4
Pages
358-364
ISSN
  • 0022-3050 (ISSN-L)
  • 1468-330X
OpenAlex
W2152018727
Cited by
185
References
33
Citations by year
2026: 2 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 11 · 2021: 20 · 2020: 14 · 2019: 14 · 2018: 15 · 2017: 14 · 2016: 20 · 2015: 18 · 2014: 17 · 2013: 14 · 2012: 11
FWCI
12.40
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5m01rr000079-42)
  • University of California, San Francisco
  • National Institute on Aging (K23AG021606, R01AG029577, P01AG017586, RF1AG029577, K23AG039414, P50AG1657303, R01AG032306, R01AG031278, K23AG031861, R01AG026251, R01AG026938, R01AG038791, P01AG019724, P50AG023501)
  • National Institute of Neurological Disorders and Stroke (R01NS065782)
  • National Center for Research Resources (M01-RR000079, M01 RR-0079)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
behavioral variant frontotemporal dementia, C9orf72 repeat expansion, frontotemporal dementia, brain atrophy, thalamic atrophy, cortical atrophy, phenocopy, neurodegeneration
MeSH terms
C9orf72 Protein, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Brain Mapping, Female, Heterozygote, Humans, Male, Middle Aged, Mutation, Neuropsychological Tests, Proteins, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review